Prolactin (PRL) acts through its receptor (PRLR) via both endocrine and local paracrine/autocrine pathways to regulate biological processes including reproduction and lactation. We analyzed the tissue-and stage of gestationspecific regulation of PRL and PRLR expression in various tissues of pigs. Abundance of pPRLR-long form (LF) mRNA increased in the mammary gland and endometrium during gestation while in other tissues it remained constant. There was a parallel increase in the abundance of the pPRLR-LF protein in the mammary gland and endometrium during gestation. We determined the hormonal regulation of pPRLR-LF mRNA expression in various tissues from ovariectomized, hypoprolactinemic gilts given combinations of the replacement hormones estrogen (E 2 ), progestin (P), and/or haloperidol-induced PRL. Abundance of pPRLR-LF mRNA in kidney and liver was unaffected by hormone treatments. Expression of uterine pPRLR-LF mRNA was induced by E 2 whereas the effect of E 2 was abolished by co-administering P. The expression of pPRLR-LF mRNA in the mammary gland stroma was induced by PRL, whereas E 2 induced its expression in the epithelium. In contrast to these changes in pPRLR expression, pPRL expression was relatively constant and low during gestation in all tissues except the pituitary. Taken together, these data reveal that specific combinations of E 2 , P, and PRL differentially regulate pPRLR-LF expression in the endometrium and mammary glands, and that the action of PRL on its target tissues is dependent upon pPRLR-LF abundance more so than the local PRL expression.
Introduction
The polypeptide hormone prolactin (PRL) regulates numerous physiological functions across multiple species. In pigs, PRL exerts its most significant effects on mammary gland growth (Farmer et al. 2000) , lactation (Farmer et al. 1998 ) and reproduction (Young et al. 1990 , Ciereszko et al. 2002 , while it also modulates biological responses including stress (Kaminska et al. 2000) and maternal behavior (Farmer et al. 1998 (Farmer et al. , 1999 . The role for PRL during mammary gland growth and lactation in swine is crucial, where inadequate milk production can impair the pre-and post-weaning growth of nursing pigs (Hurley 2001) . Development of the mammary glands of gilts in preparation for lactation depends on adequate concentrations of PRL in serum between d 90 and 109 of gestation (Farmer & Petitclerc 2003) . Postpartum suppression of serum PRL also impairs lactation and the growth of nursing pigs (Farmer et al. 1998) . Conversely, administering porcine pPRL to lactating sows does not increase nursing pig growth or mammary gland development, probably because PRL receptors (PRLR) in the mammary gland are ligand-saturated (Farmer et al. 1999) . These results suggest that PRLR abundance (as a determinant of receptor site availability) may be a major limiting factor for responsiveness of the mammary gland to PRL during lactation in pigs (Plaut et al. 1989) .
PRL primarily acts via the long form (LF) of its receptor, a member of the cytokine receptor superfamily (Lesueur et al. 1991 ) that we recently cloned from pigs (Trott et al. 2007 ). The LF is the only PRLR isoform that has been identified in pigs to date. As in other species, the pPRLR is expressed in various tissues including the mammary gland from nulliparous (Trott et al. 2007) , pregnant (Plaut et al. 1989 , Young et al. 1990 , and lactating females (Sakai et al. 1985 , Berthon et al. 1987 , liver, kidney (Trott et al. 2007) , ovary (Bramley & Menzies 1987 , Slomczynska et al. 2001 , uterus (Young & Bazer 1989) , adrenal cortex (Klemcke et al. 1989) , and brain (Muccioli et al. 1988) . However, the factors that regulate pPRLR expression have not been assessed.
While the anterior pituitary is the principal site for the synthesis and secretion of endocrine PRL, the potential exists for local autocrine/paracrine synthesis of PRL in various target tissues. Extrapituitary sources of PRL in humans, rodents, and ruminants include uterine and brain tissues, lacrimal, sweat, and adrenal glands, immune and mammary epithelial cells, skin fibroblasts, kidney, and the ovary (Fields et al. 1993 , Doppler 1994 , Ben-Jonathan et al. 1996 , Prigent-Tessier et al. 1999 , Sakai et al. 1999 , Tao et al. 2004 , Kobayashi et al. 2007 , Roselli et al. 2008 . Interestingly, PRL appears to not be expressed in the rat liver (Kurtz et al. 1993 ), a tissue rich in PRLR (Bole-Feysot et al. 1998) . In rats, PRL mRNA is first expressed within the mammary gland at midlate pregnancy and is expressed throughout lactation (Iwasaka et al. 2000) . Along these lines, precocious lactogenesis in neonatally-estrogenized nulliparous female mice coincides with elevated expression of PRL mRNA in the mammary gland (Hovey et al. 2005) . Similarly, many breast tumors in humans produce PRL that may affect disease progression (Ginsburg & Vonderhaar 1995 , Bhatavdekar et al. 2000 . While the decidua from rats and humans is a rich source of PRL and PRL-related proteins, and ruminant trophoblast cells produce placental lactogen (reviewed by Soares 2004) , the endometrium and placenta of pigs is considered to secrete neither PRL nor placental lactogen (Forsyth 1974 , DeHoff 1986 , Young & Bazer 1989 . While these data support the notion that autocrine/paracrine PRL can act on various target tissues, the extent that local PRL contributes to PRLinduced responses is unclear. Furthermore, the regulation of local PRL synthesis and the mechanisms involved are not well defined beyond a recent report that in humans, differential promoters are utilized during transcription of the PRL gene in the pituitary versus extrapituitary tissues (Gerlo et al. 2006) .
As an extension of our recent cloning of the pPRLR-LF gene and considering its candidate role in mediating the endocrine and autocrine/paracrine actions of PRL, we have analyzed pPRL and pPRLR-LF expression in various PRL target tissues of gilts during gestation. We also report the hormonal regulation of pPRLR-LF mRNA expression in hormone-depleted nulliparous females. Not only do these data reveal temporal and spatial changes in hormoneregulated pPRLR expression, but they also provide the first profile of PRL gene expression in a range of PRL-responsive tissues during gestation for any species.
Materials and Methods

Animals and tissues
Non-pregnant and pregnant pigs Meishan-derived (50% Meishan!50% hyperprolific Large White), crossbred Yorkshire!Landrace (F 1 ) and Large White multiparous sows and nulliparous gilts housed at Agriculture and Agri-Food Canada were euthanized at the following stages of development; multiparous sows at 15 d after estrus (Meishan nZ4), multiparous sows at d 15 of gestation (Meishan nZ7), gilts at d 75-76 of gestation (Large White nZ2, Yorkshire !Landrace nZ1, Meishan nZ2) or gilts at d 89-91 of gestation (Meishan nZ4). The animals were fed a commercial feed (13% CP, 3038 kcal/kg DE, 0 . 64% w/w lysine, 2 kg/d) throughout gestation and were housed in individual stalls according to a recommended code of practice (Agriculture and Agri-Food Canada 1993). The animals were heat checked daily to detect standing estrus in the presence of a mature boar and were then bred via artificial insemination. The animals were euthanized using a penetrating bolt, in accordance with the guidelines of the Canadian Council on Animal Care (Agriculture and Agri-Food Canada 1993), and the mammary gland tissue was snap frozen in liquid nitrogen and stored at K80 8C. (Farmer & Petitclerc 2003) . Animals were fed and housed as described (Farmer & Petitclerc 2003) , then were euthanized on d 110 of gestation with a penetrating bolt in accordance with the guidelines of the Canadian Council on Animal Care (Agriculture and Agri-Food Canada 1993). At necropsy, the mammary gland tissue was snap frozen in liquid nitrogen and stored at K80 8C.
Hormone-treated Yucatan miniature pigs Peripubertal
Yucatan miniature gilts housed in groups at the University of Vermont (5-months old, Sinclair Research, ME, USA) had free access to water and were fed Pig and Sow Pellets (16% CP, 2926 kcal/kg DE, 1% w/w lysine, Blue Seal Feeds, VT; 4% BW/d provided twice daily). Following hormone treatments, gilts were anesthetized with isoflurane and a blood sample was drawn prior to euthanasia with Fatal Plus (392 mg/ml pentobarbital sodium, 1 ml/4 . 54 kg, i.v., Vortech Pharmaceuticals, Dearborn, MI, USA). Liver, kidney, uterus, and mammary gland tissue was collected at necropsy, snap frozen in liquid nitrogen, and stored at K80 8C. Additional samples from 5-6 mammary glands per gilt were fixed in fresh 4% w/v paraformaldehyde in PBS (pH 7 . 4) for 24 h and then embedded in paraffin. Experiments were performed in accordance with the National Institutes of Health (NIH) Guide for The Care and Use of Laboratory Animals as approved by The University of Vermont Institutional Animal Care and Use Committee.
Yucatan miniature gilts were used in two separate studies. In Study 1, 12 gilts were administered a daily (0900 h) s.c. injection of corn oil excipient (nZ4), 17ß-estradiol (E 2 ; 0 . 1 mg/kg per d; nZ4; Sigma-Aldrich) or progesterone (P; 0 . 25 mg/kg per d; nZ4; MP Biomedicals, Solon, OH, USA), for 3 d and were euthanized 24 h after the third hormone injection. In Study 2 a total of 36 females was used across three occasions (nZ4 replicate groups, nZ9 treatments). Four control gilts were sham-ovariectomized while 32 gilts were ovariectomized. All pigs were sedated with ketamine (20 mg/kg, i.m.) and atropine (6 . 7 mg/kg, i.m.) prior to isofluorane anesthesia and surgical removal of their ovaries or sham ovary removal. All animals received postoperative s.c. injections of penicillin and flunixin meglumine analgesic along with immediate access to food and water. Starting the next day, ovariectomized gilts received (Bromo; 0 . 1 mg/kg per d i.m.; Sigma-Aldrich) for 8 d to block PRL secretion (Farmer et al. 1998 (Farmer et al. , 2000 . Thereafter, the ovariectomized gilts were randomly assigned to one of the eight treatment groups (nZ4 per group); Bromo, Bromo CE 2 , BromoCP, BromoCE 2 CP, haloperidol (Hal), Hal CE 2 , HalCP, or HalCE 2 CP. Animals were injected i.m. Sigma-Aldrich; to induce endogenous PRL release) for 5 d. All hormone injections were diluted and administered in saline (w1 . 2 ml) at 0900 h with the final injection administered !3 h before euthanasia. Sham-ovariectomized gilts received daily injections of saline for 14 d. All gilts were euthanized on 14 d after ovariectomy or sham-ovariectomy.
Serum hormone RIAs
Solid phase RIAs for E 2 and P were performed by the Animal Health Diagnostic Center Endocrinology Laboratory (Veterinary College, Cornell University, Ithaca, NY, USA). Samples assayed for E 2 were extracted with ethyl ether, and [ 3 H]E 2 was used to determine recovery for each sample (mean recovery was 77 . 4%). The sensitivity of the assays for E 2 and P was 0 . 02 ng/ml and 6 . 0 pg/ml, respectively (Reimers et al. 1991) .
The intra-assay coefficient of variation for the E 2 and P assays were 18 . 9 and 5 . 6% respectively. The inter-assay coefficients of variation (CV) for the E 2 and P assays were 10 . 7 and 8 . 3%
respectively. pPRL in serum was measured using a homologous pPRL RIA, with purified pPRL (National Hormone and Peptide Program, Torrance, CA, USA) as the standard and 125 I-pPRL as the ligand. Sensitivity of the assay was 0 . 25 ng/ml. Intra-and inter-assay CV were 2 . 1 and 2 . 0% (Horigan et al. 2009 ).
RNA extraction and reverse transcription
Tissue samples were homogenized in Trizol (Invitrogen) and total RNA precipitated according to the manufacturer's instructions. Total RNA (7 mg) was treated with DNAseI (Roche Molecular Systems) and purified using a DNA-Free RNA Kit (Zymo Research Corporation, Orange, CA, USA) prior to confirmation of its integrity by formaldehydeagarose gel electrophoresis. Total RNA (0 . 5 or 1 mg) from each sample was then reversed transcribed into cDNA using 5! RT Buffer (Promega), oligo dT (20 ng/ml, Amersham Pharmacia Biotech, Inc.), dNTP mixture (0 . 4 mM, Promega), random hexamers (2 ng/ml, Amersham Pharmacia Biotech, Inc.), Moloney's murine leukemia virus (MMLV) reverse transcriptase (4 U/ml Promega), and RNAse inhibitor (1 U/ml, Stop Rnase Inhibitor, 5 Prime Inc., Gaithersburg, MD, USA) by incubation at 25 8C for 5 min, 37 8C for 60 min, and 95 8C for 5 min.
Real-time TaqMan quantitative PCR
Primer and probe sets for Taqman quantitative PCR (qPCR) were designed from the predicted Yucatan miniature pig pPRLR-LF specific sequence (AY308824) and GenBank sequence for Sus scrofa 18S rRNA (AY265350) using primer express. Probes were labeled with 6-carboxyfluorescein (6-FAM) and black hole quencher-1 (BHQ-1; Biosearch Technologies, Novato, CA, USA). The primer and probe sequences are presented in shown). In all other studies the level of pPRLR-LF mRNA expression was determined using a relative standard curve. A standard curve was prepared using between 5 and 6 fourfold serial dilutions of a sample known to have high levels of target gene expression. One standard curve was used for all q-PCR plates within an experiment and was dispensed in duplicate.
All standard curves had a linear regression coefficient of determination of at least 97%. Standard curves were generated by linear regression using C t versus log (dilution factor). The pPRLR and 18S rRNA levels in each sample were calculated from C t values using the standard curve. Data were expressed as the ratio between pPRLR-LF and the 18S rRNA expression levels, yielding a normalized relative expression level of pPRLR-LF mRNA.
Real-time qPCR (SYBR Green)
Primer sequences for PRL given in Table 1 were designed from the Genbank sequence for S. scrofa PRL (NM_213926) to span exons 2 and 3. Reverse transcribed, DNase-treated total RNA was amplified by qPCR using SYBR Green JumpStart Taq ReadyMix (Sigma), 0 . 15 mmol/l primers and 2 ml cDNA on an ABI7700 Sequence Detection System (Applied Biosystems). The reaction conditions for the PRL primers were 95 8C for 2 min, then 40 cycles of 95 8C for 30 s followed by 58 8C for 30 s and 72 8C for 30 s. Each PCR run included a no-template control containing all reagents except cDNA and a reverse transcription negative control reaction that was performed in the absence of MMLV reverse transcriptase. Melting curve analysis showed a single amplification product that was sequenced to confirm its identity as pPRL mRNA. The level of PRL mRNA expression was normalized to 18S rRNA using a relative standard curve as described above.
In situ hybridization
In situ hybridization for pPRLR mRNA was performed on paraffin-embedded tissue sectioned at 4 mm. The methods used were described previously (Spencer et al. 1999) . Briefly, deparaffinized, rehydrated sections of the mammary gland were treated with protease and then hybridized with an [a-35 S]UTP labeled sense or antisense cRNA probe generated from a linearized plasmid template containing partial cDNA (717 bp) for the pPRLR extracellular domain that detects all isoforms of the pPRLR. After hybridization, washing, and ribonuclease A digestion, slides were dipped in NTB-2 liquid photographic emulsion (Kodak), stored at 4 8C for 30 d, and developed in a Kodak D-19 developer. Slides were then counterstained with Gill's modified hematoxylin (Stat Lab, Lewisville, TX, USA), dehydrated through a graded series of alcohols to citrisolve, and coverslipped. Images of the representative fields were recorded using a Nikon Eclipse 1000 photomicroscope (Nikon Instruments Inc., Lewisville, TX, USA) fitted with a Nikon DXM1200 digital camera.
Mammary gland and endometrial membrane preparation
Mammary gland parenchyma and endometrium (1-2 . 5 g) from pregnant UHO gilts (d 45, 65, 85 and 105 of gestation; nZ2) was homogenized in 25 ml Tris-EDTA buffer (25 mmol/l Tris, 1 mmol/l EDTA, 0 . 25 mol/l sucrose, 1 mmol/l glutathione, pH 7 . 4). The homogenate was filtered through a cheesecloth and centrifuged at 11 000 g for 20 min at 4 8C. The supernatant was then filtered through a cell strainer (100 mm; BD Falcon, Franklin Lakes, NJ, USA) and ultracentrifuged at 100 000 g for 1 h at 4 8C. The pellet was resuspended in 1 . 25 ml buffer (25 mmol/l Tris, 0 . 02% w/v NaN 3 , pH 7 . 2) and analyzed for pPRLR by western blotting.
Immunoprecipitation of PRL
Mammary gland samples from the UHO gilts on d 25 and 105 of gestation and sows at d 21 of lactation (nZ2) were homogenized in buffer (25 mmol/l Tris pH 7 . 5, 2 mmol/l MgCl 2 , 1 mmol/l EDTA, 1 mmol/l DTT, 0 . 5 mg/ml leupeptin (Roche), 0 . 7 mg/ml pepstatin A (Roche), 1 mg/ml aprotinin (Roche), 10 mg/ml soybean trypsin inhibitor (Roche), 20 mg/ml phenylmethylsulfonyl fluoride (Roche), 1% v/v Triton X-100). Total protein (0 . 75 mg) was incubated with 0 . 02% v/v rabbit polyclonal IgG a-pPRL antiserum (National Hormone and Peptide Program) for 5 h at 4 8C before the addition of 30 ml protein A/G PLUS Agarose (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and agitation overnight at 4 8C. The immunoprecipitated complex was washed four times with PBS and the pellet boiled in loading dye prior to electrophoresis and western blotting. Fig. 4) were analyzed using student's t-test. Data from ovariectomized hormonetreated Yucatan miniature pigs (Study 2; Fig. 6 ) were analyzed using ANOVA (blocked for date) followed by a TukeyKramer multiple means comparison. In addition the main effects of E 2 , P, and Hal and their interactions were tested by factorial analysis. Levels of statistical significance are indicated in the results and figure legends.
Results
Tissue-specific regulation of pPRLR-LF transcription during gestation
Given that the mammary gland is a primary target for PRL, we first examined pPRLR-LF mRNA levels within the mammary glands of nulliparous and pregnant pigs. On d 15 of gestation the level of pPRLR-LF mRNA was not different to that in nulliparous females sampled on d 15 after estrus (Fig. 1) . During gestation the level of pPRLR-LF mRNA expression in the mammary glands was increased at d 75-76, and was maximal on d 89-91 (P!0 . 05). We next examined pPRLR-LF mRNA in various other tissues from gilts at different stages of gestation. The highest levels of pPRLR-LF mRNA were present in adrenal glands, endometrium and mammary glands (P!0 . 05), while the lowest levels were in brain, hypothalamus, liver and ovary (P!0 . 05; Fig. 2) . A low level of pPRLR-LF mRNA was also detectable in adipose and spleen but it was barely detectable in other tissues including lung, muscle, diaphragm, lymph nodes, thymus, and heart (data not shown). The level of pPRLR-LF mRNA in the mammary glands increased linearly over time (P!0 . 05; Fig. 2D ), consistent with the data presented in Fig. 1 . There was a similar linear increase in pPRLR-LF mRNA expression in the endometrium during gestation (P!0 . 05; Fig. 2B ).
There was an overall increase in the pPRLR-LF mRNA expression during gestation in the hypothalamus that followed a cubic regression curve (P!0 . 05) whereby it rose early, and then again later, during gestation (Fig. 2C) . Levels in the placenta rose in mid gestation and dropped again, following a quadratic regression curve (P!0 . 05; Fig. 2E ). By contrast, the level of pPRLR-LF mRNA in adrenal, brain, kidney, liver, ovary, and pituitary remained unchanged during gestation. These data indicate that transcription of the pPRLR-LF in various PRL-responsive tissues from pigs is differentially regulated during gestation. We sought to establish whether the levels of pPRLR-LF protein in the mammary gland and endometrium during gestation coincided with the pPRLR-LF mRNA levels. As shown in Fig. 3 , pPRLR-LF in the mammary gland and endometrium of pregnant gilts was detected as a protein of w85 kDa, consistent with our earlier findings (Trott et al. 2007) . The abundance of pPRLR-LF protein in the mammary gland and endometrium during gestation paralleled the increasing levels of mRNA reported above. Therefore, translation of the pPRLR-LF in the mammary gland and endometrium increases during gestation and mirrors changes in mRNA abundance.
Hormonal regulation of pPRLR-LF mRNA levels in various tissues
The finding that pPRLR-LF mRNA expression during gestation increased within the mammary glands and endometrium, but not in liver or kidney, led us to examine the hormonal regulation of pPRLR-LF mRNA expression in these tissues. Two studies were conducted using hormonetreated Yucatan miniature pigs. In Studies 1 and 2, the administration of exogenous E 2 increased its level in serum (P!0 . 05; Study 1, 471G179 vs 29G7 pg/ml; Study 2, 3432G440 vs 22G2 pg/ml). In Study 1, the administration of exogenous P tended to increase its level in serum up to 24 h after injection (P!0 . 07; 26G9 vs 7G2 ng/ml). In Study 2 we used medroxyprogesterone 17-acetate that precluded its detection in serum due to unavailability of a suitable assay. In Study 2, serum PRL levels were increased by treatment with Hal compared with saline controls (P!0 . 0001; 30 . 5 G5 . 4 vs 2 . 4G0 . 8 ng/ml) and decreased by Bromo-treatment compared with saline controls (P!0 . 05; 0 . 8G0 . 04 vs 2 . 4 G0 . 8 ng/ml).
We first measured pPRLR-LF mRNA expression in ovaryintact nulliparous Yucatan miniature gilts that were treated for 3 d with exogenous E 2 or P. While the level of pPRLR-LF mRNA differed across the tissues examined, it was unchanged in mammary gland, kidney, ovary, uterus, and liver following treatment with E 2 or P (Fig. 4) , although in the uterus it tended to be reduced by P (P!0 . 08). Bromo administered to gilts between d 90 and 109 of gestation inhibits mammary gland growth and subsequent galactopoiesis (Farmer et al. 1998 , Farmer & Petitclerc 2003 . We therefore anticipated a reduction in pPRLR-LF mRNA within the mammary glands of pregnant gilts treated with Bromo from d 90 to 109 of gestation. As shown in Fig. 5 , administering Bromo during pregnancy for these 20 d had no effect on pPRLR-LF mRNA expression at d 109 compared with the control gilts, despite its previously-documented negative effect on mammogenesis (Farmer & Petitclerc 2003) . Treating pregnant gilts for 20 d with Bromo also did not change the number of PRL binding sites on the mammary gland membrane preparations at d 109 of gestation (Farmer & Petitclerc 2003) .
We next sought to define the individual hormones that regulate pPRLR-LF mRNA expression in vivo. Given the potential confounding effects of a hormonal background in ovary-intact females, we examined pPRLR-LF mRNA expression in tissues from ovariectomized Yucatan miniature gilts treated with either Bromo or Hal in the presence or absence of E 2 and/or P. There was a positive main effect of Hal on pPRLR-LF mRNA levels in the mammary gland (PZ0 . 001; Fig. 6A ). Levels of pPRLR-LF mRNA in the uterus were increased by treatment with E 2 (PZ0 . 001) or E 2 CHal (P!0 . 01; Fig. 6B ) when compared to those in ovariectomizedCBromo gilts. There was also a positive main effect of E 2 on pPRLR-LF mRNA levels in the uterus (PZ0 . 001). Intriguingly, there was an interaction between E 2 and P (P!0 . 05) whereby P reduced the positive effects of E 2 , regardless of whether PRL was present or not (Fig. 6B) . The level of pPRLR-LF mRNA in kidney and liver was unaltered by any combination of exogenous E 2 , P, or Hal relative to that in hormone-depleted gilts (Fig. 6C and D) , consistent with the data in Figs 2 and 4. In a separate qPCR analysis using primers within the extracellular domain of the pPRLR, there was no difference between the changes in pPRLR-LF mRNA and total pPRLR mRNA levels in the mammary glands following the various hormone treatments (data not shown).
Given that the mammary glands are a primary target for PRL, we also examined total pPRLR mRNA distribution within the mammary glands of the hormone-treated ovariectomized gilts by in situ hybridization. As shown in Fig. 7 , ovariectomy and treatment with Bromo downregulated the expression of pPRLR mRNA within the stroma (Fig. 7A versus B-E) . Treatment with E 2 induced a marked increase in pPRLR mRNA expression specifically in the mammary epithelium (Fig. 7C, E, G, I versus B) . There was no obvious effect of P alone (Fig. 7D) , or in combination with E 2 (Fig. 7E) . By contrast, treatment with Hal ( Fig. 7F-I ) restored stromal pPRLR mRNA expression to levels similar to or greater than the saline controls (compare to Fig. 7A ). These data indicate that dynamic changes in pPRLR mRNA expression and distribution within the mammary glands is regulated by specific endocrine cues, whereby E 2 induces its expression in the mammary epithelium whereas hyperprolactinemia induces its expression in the stroma.
Expression of PRL mRNA in various tissues
We also sought to establish whether hormonal and developmental regulation of pPRLR-LF expression in various porcine tissues is accompanied by changes in the local expression of paracrine/autocrine PRL. We first analyzed PRL mRNA expression in tissues from gilts at various stages of gestation. As anticipated, the highest levels of PRL mRNA expression were detected in the pituitary (P!0 . 0001; Fig. 8 ).
There was no change in PRL mRNA abundance during gestation in any of the tissues examined apart from a trend for pituitary PRL mRNA expression to increase linearly (PZ0 . 07). With respect to the overall abundance of PRL mRNA in the extra-pituitary tissues, levels in hypothalamus were higher than in kidney, liver, and ovary (P!0 . 05) while all other tissues had similar PRL mRNA levels.
Immunoreactive PRL in the mammary gland
We evaluated immunoreactive pPRL in extracts of mammary gland from gilts at different stages of gestation and lactation. As shown in Fig. 9 , immunoreactive PRL was detected in the mammary gland at 25 and 105 of gestation and d 21 of lactation. The pPRL was 23 kDa while some slightly smaller forms were also detected (19-23 kDa).
Discussion
PRL elicits a wide range of important biological functions, particularly during lactation and reproduction. Among other considerations, pigs are unique among the Artiodactyla order in their requirement for pituitary PRL to Means with a different superscript are significantly different (P!0 . 05).
J F TROTT and others . Regulation of pig prolactin receptors maintain their corpora lutea and thus their pregnancy (Anderson et al. 1967 , Forsyth 1986 ). In these studies we hypothesized that developmental changes in pPRLR-LF expression in pigs during gestation were hormonallyregulated, and that local PRL expression contributed to PRL-regulated mammogenesis.
Our results reveal that the endocrine environment differentially regulates pPRLR-LF expression in the mammary glands and uterus during development, and likely directs the pregnancy-associated changes in pPRLR-LF mRNA levels in the hypothalamus and placenta. The levels of pPRLR mRNA and protein increased in the mammary glands and endometrium during gestation, consistent with the findings from a previous study using a heterologous radioreceptor assay that measured pPRL binding (DeHoff 1986) . The increasing expression of pPRLR-LF mRNA in the mammary glands of pigs during gestation contrasts with its profile in this tissue from mice wherein PRLR-LF mRNA levels decrease during gestation (Hovey et al. 2001) . However, our data are remarkably similar to the profile for PRLR during gestation in sheep (Cassy et al. 1998 ) and rats (Varas & Jahn 2005) .
The increase in pPRLR levels occurs prior to the peak of PRL in serum at parturition (DeHoff et al. 1986 , Plaut et al. 1989 , Farmer et al. 2000 , and likely prepares the mammary gland for lactogenesis. Within the porcine endometrium, an increase in pPRLR-LF mRNA levels during gestation mirrors the increase in pPRLR-LF mRNA expression in the ovine endometrium (Stewart et al. 2000) . This profile of increasing pPRLR-LF mRNA fits with the hypothesis that uterine PRLR are essential for maintaining pregnancy during late gestation (Reese et al. 2000) . Given that E 2 stimulates, and P suppresses, expression of pPRLR-LF mRNA in the uterus, the increasing expression of pPRLR-LF during gestation is likely driven by increasing serum E 2 and decreasing serum P concentrations, starting around d 40 of gestation (Eldridge-White et al. 1989) .
The pregnancy-associated increase in pPRLR-LF mRNA abundance in the porcine hypothalamus is consistent with data from rats where PRLR-LF mRNA expression during gestation increases in the arcuate nucleus and choroid plexus (Augustine et al. 2003) as well as in oxytocin-expressing neurons in the paraventricular nuclei of the hypothalamus ( Kokay et al. 2006) . PRL regulates its own secretion at the level of the hypothalamus, where the wide influence of PRL on brain functions is thought to be required for neurobiological adaptations during preparation for pregnancy and lactation . The detection of pPRL mRNA expression in the brain and hypothalamus was expected given data from rats , sheep (Roselli et al. 2008) , and mice (Chen et al. 2004) . Combined, these data suggest that PRL may mediate some actions in the brain by acting as a neuropeptide as well as a neuroendocrine hormone .
Our results indicate that E 2 and PRL both induce pPRLR mRNA expression in the mammary glands, albeit in different cell types. In the mammary glands of mice ovariectomized during early pregnancy, both E 2 and PRL upregulate PRLR-LF mRNA expression, while it is suppressed by P (Mizoguchi et al. 1997) . PRL upregulates PRLR levels in the mammary glands of pseudopregnant rabbits, while P prevents this PRL-induced upregulation (Djiane & Durand 1977) . Given these data and our present findings, it appears that the suppressive effect of P on PRLR expression is restricted to the pregnant state. The stimulation of PRLR expression by E 2 has previously been attributed to its indirect effect on PRL secretion from the pituitary (Sheth et al. 1978 , Hayden et al. 1979 . However, here we show that E 2 has a direct positive effect on pPRLR expression, specifically in mammary epithelial cells, during hypoprolactinemia induced by co-administered Bromo. While it is possible that this effect of E 2 on pPRLR mRNA levels in the mammary epithelium is specific to pigs, it is more likely that this cell type-specific induction of PRLR mRNA is not revealed using methods that analyze the entire tissue, as we found in this study. The lack of any effect of Bromo on pPRLR-LF mRNA levels in the Figure 7 In situ hybridization analysis of pPRLR mRNA expression within the mammary glands from hormone-treated ovariectomized Yucatan miniature gilts. Protected transcripts in mammary glands from gilts treated with combinations of replacement hormones were visualized by liquid emulsion autoradiography, and imaged under bright-field (hematoxylin staining) and dark-field (a-35 S-PRLR signal) illumination. A representative section from an E 2 CHal treated gilt hybridized with radiolabeled sense strand cRNA (sense) was the negative control. Gilts were either (A) ovary-intact, saline treated, or ovariectomized and treated with (B) Br, (C) BrCE 2 , (D) BrCP, (E 2 ) BrCE 2 CP, (F) Hal, (G) HalCE 2 , (H) HalCP, (I) HalCE 2 CP. Scale barZ100 mm. E 2 , 17ß-estradiol; Br, bromocriptine; P, medroxyprogesterone 17-acetate; dl, ductal lumen; st, stroma.
mammary glands of pregnant gilts may be due to the dramatic rise in E 2 concentrations (0-4500 pg/ml) occurring in the second half of pregnancy (Eldridge-White et al. 1989) that is probably stimulating the increase in pPRLR-LF mRNA expression observed during gestation. We hypothesize that Bromo may suppress pPRLR-LF mRNA levels specifically in the mammary stroma of late pregnant gilts, a change that is not obvious using whole-tissue q-PCR analyses but that would be detectable using in situ hybridization.
In contrast to the mammary glands, the major determinant of pPRLR-LF mRNA expression in the uterus is E 2 , as has been reported by others (Young et al. 1990 ). However, whereas Young et al. (1990) found that long-term (11 d) treatment with E 2 reduced the number of PRLR binding sites in the endometrium, we observed a significant increase in pPRLR-LF mRNA expression after 5 d treatment with E 2 . This discrepancy may reflect differences in treatment length, time between the final hormone injection and subsequent tissue collection (3 vs 24 h), or the dose used, where our study produced levels of E 2 at least as high as those found on d 110 of pregnancy (Winn et al. 1993) .
Our data from ovariectomized, PRL-deficient gilts indicate that P alone does not regulate pPRLR expression in the mammary gland or uterus. This finding is consistent with the outcome of PRL binding to the endometrium from ovariectomized, P-treated gilts (Young et al. 1990 ). We now demonstrate that P suppresses the ability of E 2 to induce pPRLR-LF mRNA expression specifically within the uterus. This negative effect of P also likely accounts for its tendency to downregulate pPRLR-LF mRNA expression within the uterus of ovary-intact females. On the other hand, expression of pPRLR-LF mRNA levels in the liver and kidneys was insensitive to the various combinations of E 2 , P, and PRL, despite the fact that all these tissues are targets for PRL (Bole-Feysot et al. 1998 ). In fact, early studies using hypophysectomized rats showed that PRL upregulates PRLR in the liver (Posner et al. 1975) . While it is possible that species differences exist for the hormonal responsiveness of liver PRLR, it is also possible that regulation of liver PRLR expression is not as sensitive to changes in PRL concentrations as mammary or endometrial PRLR. Such differential responsiveness emphasizes the coordinated control of pPRLR expression during gestation. These differences likely involve cell type-and tissue-specific, hormone-sensitive regulatory factors as well as differential promoter utilization within the PRLR gene (Hu et al. 1996 , Ormandy et al. 1998 .
We identified that lung, muscle, diaphragm, lymph nodes, thymus, and heart contained barely-detectable levels of pPRLR-LF mRNA during gestation while endometrium, adrenal, and mammary glands had the highest levels. These profiles of PRLR mRNA abundance across different tissues at different stages of development are essentially the same as reported for human tissues (Peirce & Chen 2001 , Trott et al. 2003 . Similar to our findings in pigs, rabbits express low levels of PRLR in the liver whereas the levels in the ovary are high (Dusanter-Fourt et al. 1991) . By comparison, some of the highest levels of the PRLR-LF are found in the liver Figure 9 Immunodetection of pPRL in vivo. Extracts of the mammary gland from four UHO gilts at the indicated stages of gestation (gest) or from two multiparous sows at d 21 of lactation were immunoprecipitated, resolved under reducing conditions, and immunoblotted with a polyclonal a-pPRL antiserum. The migration of molecular size markers is indicated. and ovaries of rats (Nagano & Kelly 1994) . Consistent with our previous work (Hovey et al. 2001) , we now show that pPRLR levels are differentially-regulated during development in a tissue-specific manner, thereby precluding a direct comparison of PRLR levels in various tissues across species. However, the question does remain as to whether there are tissue-specific roles for the PRLR within and between species.
Several groups have proposed that the extrapituitary synthesis of PRL may serve as a local mechanism for PRLR activation (Clevenger & Plank 1997 , Ormandy et al. 2003 .
Within this study we detected a tendency (PZ0 . 07) for PRL gene expression in the pituitary to increase linearly during gestation, whereas PRL gene expression was constant in all other tissues. The dramatic rise in serum PRL during late gestation to a peak of w100-200 ng/ml around parturition generally begins around d 105, when levels are still only w15 ng/ml. However, there is a tendency for levels to rise from wd 70-75 to wd 105-110 (DeHoff et al. 1986 , Farmer et al. 2000 . Thus, the linear increase in pituitary PRL mRNA expression that we observed from d 25 to d 105 of gestation may be reflected by this small rise in serum PRL later in gestation prior to the peak at parturition. During gestation there was a tissue-specific increase in pPRLR-LF expression within the endometrium, hypothalamus and mammary gland without any change in their expression of pPRL mRNA. These data suggest that endocrine PRL is likely the major effector of PRL action on peripheral tissues in pigs, and that responsiveness to PRL is conferred primarily via tissuespecific changes in pPRLR-LF transcription and translation. Also noteworthy is our finding that PRL gene expression in the placenta of gestating pigs was no higher than in other extrapituitary tissues. This finding affirms limited evidence that the pig placenta is not a major source of lactogenic hormones (Forsyth 1974 , DeHoff 1986 , where these determinations were made using either radioreceptor assays or by co-culturing placenta with mouse or rabbit lobuloalveolar tissue and measuring a lactogenic response. The low levels of PRL mRNA that we measured in placenta does not preclude the synthesis of other PRL-related proteins by this tissue, although other evidence also indicates that pigs depend on pituitary PRL to maintain their corpora lutea and pregnancy (Anderson et al. 1967) . Certainly the rise and fall in placental PRLR mRNA levels during gestation, as also occurs for PRLR in rat decidual tissue ( Jayatilak & Gibori 1986 , Gu et al. 1996 , suggests that this tissue is differentially responsive to PRL during pregnancy. What remains unclear is how, or why, PRL transcription is suppressed in the placenta of pigs, given that many other species express a relative abundance of PRL in this tissue (Prigent-Tessier et al. 1999 , Soares 2004 . Likewise, the potential role for the placenta to produce various PRLrelated proteins requires consideration given their more recent identification in other livestock species (Larson et al. 2006 , Ushizawa et al. 2007a .
Our in situ hybridization analysis revealed the novel finding that PRL upregulated the expression of PRLR mRNA primarily in the stromal compartment of the mammary gland whereas E 2 upregulated its expression specifically in the epithelium. This approach revealed hormone-induced changes that were not apparent in whole tissue analysis by qPCR. While the role for stromal PRLR in the mammary gland is unclear, it apparently does not contribute to branching morphogenesis in mice (Ormandy et al. 2003) . On a related note, we did find that pPRLR-LF mRNA was expressed in adipose tissue (data not shown), as occurs in humans (Ling et al. 2000 , Zinger et al. 2003 . Furthermore, our current data align with our previous demonstration of stage-specific PRLR isoform expression in the stroma of mammary glands from neonatal mice (Hovey et al. 2001) . Combined, these data support the potential for endocrine PRL to modulate crosstalk between epithelial and stromal cells in the mammary gland, although the precise contribution(s) of this relationship to mammary gland function remains unresolved.
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